|
|
ProResolvin Bovine trachea is composed almost exclusively of cartilage, and liquefied tracheal cartilage represents a useful source of this tissue. Liquid Bovine Tracheal Cartilage (LBTC) has been demonstrated to have potent action in a variety of therapeutic uses, the main ones being in the treatment of immune dysfunction and connective tissue injuries/weakness. Clinical Applications Arthritis Osteoarthritis Wound healing Post-surgery Post-trauma Autoimmune diseases Rheumatoid arthritis Ankylosing spondylitis Systemic lupus erythematosis (SLE) Inflammatory conditions Psoriasis Pelvic inflammatory disease Dermatitis Pruritis Alveolitis Gout Repetitive Strain Injury Immunity regulation Cancer Inhibition Wound healing Cartilaginous tissue is known to consist of various factors including chondroitin sulphate, glucosamine, hexosamine, assumed that the chondroitin sulphate fractions were the active agents, however, recent research shows that the long chain molecules, of which cartilage is composed, are probably responsible3 . Whatever the action, there is no doubt that osteoarthritis, rheumatoid arthritis, psoriasis, pelvic inflammatory disease, dermatitis, pruritis, alveolitis, gout, RSI and non-specific inflammatory muscular problems all respond with high rates of success4. Restoring cartilage integrity within a joint is obviously beneficial in degenerative joint disease and bovine cartilage supplementation is the most relevant and effective means of nourishing this tissue and resolving the degeneration of the weight bearing surfaces.
Autoimmune Diseases Bovine tracheal cartilage supplementation has been shown to have immune regulating properties.5 The bovine tracheal cartilage is therefore useful in conditions such as rheumatoid arthritis, ankylosing spondylitis and systemic lupus erythematosis.
Digestive system Bovine tracheal cartilage’s anti-inflammatory effects make it especially useful for joint disorders, however it has also been shown to be very effective in inflammatory conditions of the gut. These conditions include Crohn’s disease and ulcerative colitis which respond well to oral liquid bovine tracheal cartilage.6
Summary Liquefied bovine tracheal cartilage is a very exciting therapeutic tool for conditions which typically take some time to respond, and for which there are few therapeutic items currently available. It has a diverse range of treatment applications, including arthritis, inflammation conditions, wound healing and autoimmune conditions. Both oral and topical application of liquid cartilage will enhance healing of connective tissue and resolve inflammatory conditions. REFERENCES 1 Prudden JF, Wolarsky ER. The acceleration of wound healing. Surg Gynecol Obst 1969. 128: 1321-1326 2 Prudden JF, Balassa LL. The biological activity of bovine cartilage preparations. Seminars Arth. And Rheum. 1974; 3: 287-321 3 Sichel M. The Medifile Report Dec 1997 4 Taken from tables of results from Dr. John Prudden’s book "The Journey" 5 Rosen J et al. Immunoregulatory effects of catrix. J Biol Response Modifiers 1988; 7: 498-512 6 Prudden JF et al. The biological activity of bovine cartilage preparations. Sem Arthritis & Rheum 1974; 3(4): 287-321 MOREBovine Cartilage stimulates the production of B-Lymphocytes and through inhibition of the process of angionesis Bovine Tracheal Cartilage inhibits some types of cancer Including: the regression or remission of some cases of Breast cancer, and causing the regression of the cancerous cells involved in Cervical cancer [documented cases exist of total regression of Cervical cancer without recurrence after eight years]. Bovine Tracheal Cartilage has been successful in the treatment of some cases of Kidney cancer, Ovarian cancer, Pancreatic cancer, Prostate cancer, Squamous Cell Carcinoma, Gliablastoma, and Non Hodgkins Lymphoma. - References: Durie, Brian G.M., et al., An assessment of the anti-mitotic activity of catrix-s in the human stem cell assay. Journal of Biological Response Modifiers. 4:590-95, 1985. Kirchhof, D., et al. The successful use of bovine tracheal cartilage in the treatment of cancer. Kriegel & Associates Publishers, Belgrade, MT, 1995. Prudden, J. F. The treatment of human cancer with agents prepared from bovine cartilage. Journal of Biological Response Modifiers. 4:551-584, 1985. Puccio, C., et al. The treatment of metastatic renal cell carcinoma with catrix (Meeting Abstract). Proceedings from the annual meeting of the American Society of Clinical Oncology. 13:A769, 1994. Prudden, J. F., et al. The biological activity of bovine cartilage preparations. Sem. Arthritis & Rheum. 3(4):287-321, 1974. Rosen, J. et al. Immunoregulatory Effects of Catrix. Journal of Biological Response Modifiers. 7:498-512, 1988. Prudden, J. F., et al. The biological activity of bovine cartilage preparations. Sem Arthritis & Rheum. 3(4):287-321, 1974.
|
|
|